Stocks of Alignment Healthcare Inc. (NASDAQ:ALHC) traded higher last session on Wall Street, down -4.08% to $11.05.
According to the data, Alignment Healthcare Inc. (NASDAQ:ALHC) has 10 analysts covering its stock. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $24.00 and a low of $14.50, we find $19.00. Given the previous closing price of $11.52, this indicates a potential upside of 64.93 percent. ALHC stock price is now -10.06% away from the 50-day moving average and -10.75% away from the 200-day moving average. The market capitalization of the company currently stands at $2.16B.
Top 5 Undervalued Stocks To Own In 2023
Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.
Click here to download your Free Research Report…
Sponsored
A total of 2 analysts have issued a hold rating and 8 have given it a buy rating. Brokers who have rated the stock have averaged $19.19 as their price target over the next twelve months.
, while ‘BofA Securities’ rates the stock as ‘Buy’.
In other news, Kumar Dinesh M., Chief Med & Operating Officer sold 1,000 shares of the company’s stock on Jan 03. The stock was sold for $12,013 at an average price of $12.01. Upon completion of the transaction, the Chief Med & Operating Officer now directly owns 1,126,226 shares in the company, valued at $12.44 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 21, President, Markets Maroney Dawn Christine sold 4,274 shares of the business’s stock. A total of $51,345 was realized by selling the stock at an average price of $12.01. This leaves the insider owning 1,970,692 shares of the company worth $21.78 million. Insiders disposed of 29,465,348 shares of company stock worth roughly $325.59 million over the past 1 year. A total of 4.10% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in ALHC stock. A new stake in Alignment Healthcare Inc. shares was purchased by T. ROWE PRICE INVESTMENT MANAGEMENT, INC. during the first quarter worth $81,341,000. MARSHALL WACE, LLP invested $31,850,000 in shares of ALHC during the first quarter. In the first quarter, LOOMIS SAYLES & CO L P acquired a new stake in Alignment Healthcare Inc. valued at approximately $16,989,000. JACOBS LEVY EQUITY MANAGEMENT, INC acquired a new stake in ALHC for approximately $6,917,000. CAAS CAPITAL MANAGEMENT LP purchased a new stake in ALHC valued at around $6,437,000 in the second quarter. In total, there are 163 active investors with 84.20% ownership of the company’s stock.
Friday’s opening bell rang with an opening price of $11.59 for Alignment Healthcare Inc. (NASDAQ: ALHC). During the past 12 months, Alignment Healthcare Inc. has had a low of $6.14 and a high of $19.17. As of last week, the company has a debt-to-equity ratio of 0.59, a current ratio of 2.00, and a quick ratio of 2.00. The fifty day moving average price for ALHC is $12.25 and a two-hundred day moving average price translates $12.38 for the stock.
The latest earnings results from Alignment Healthcare Inc. (NASDAQ: ALHC) was released for Jun, 2022. According to the Healthcare Plans Company, earnings per share came in at -$0.06, beating analysts’ expectations of -$0.26 by 0.2. This compares to -$0.26 EPS in the same period last year. The net profit margin was -10.20% and return on equity was -48.20% for ALHC. The company reported revenue of $360.35 million for the quarter, compared to $293.47 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 22.79 percent. For the current quarter, analysts expect ALHC to generate $333.4M in revenue.
Alignment Healthcare Inc.(ALHC) Company Profile
Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, and Nevada. It also coordinates and provides covered health care services, including professional, institutional, and ancillary services to members enrolled in certain benefit plans of unaffiliated Medicare Advantage Health Maintenance Organizations. The company was founded in 2013 and is based in Orange, California.
